| Serial Number | 98223255 |
| Word Mark | EXOFUSION |
| Filing Date | Friday, October 13, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, October 1, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of Exofusion shape colors are grey white and black. |
| Goods and Services | Supplements and Vitamins |
| Indication of Colors claimed | The color(s) gray, black and white is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 17, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | exofusion LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lorton, VA 22079 |
| Event Date | Event Description |
| Tuesday, October 17, 2023 | NEW APPLICATION ENTERED |
| Tuesday, October 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 31, 2024 | ASSIGNED TO EXAMINER |
| Saturday, June 1, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, June 1, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 18, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, June 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, October 1, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |